The Venture Codex

Led · Seed · Jun 2026

Ladder Health delivers virtual-first, AI-enabled developmental and therapeutic care for children, providing speech, occupational, physical, and feeding therapy through a model that activates caregivers as therapeutic partners. The platform offers evenings and weekends access and emphasizes extending care into the home to reduce wait times from months to days. Ladder partners with pediatric practices and health systems as a referral and care-extension partner and reports working with more than 80 provider organizations and health systems across Massachusetts, North Carolina, and Maryland. The company was incubated by 25madison and developed in collaboration with clinical experts at Boston Children's Hospital, which holds equity in Ladder. Current plans highlighted by the company include geographic expansion into additional states and continued investment in its AI-enabled care platform and health system integrations. Ladder positions its model as a scalable response to pediatric workforce shortages and the surge in demand for developmental services.

Participated · Series A · Mar 2026

Rivia has built a unified data engine that integrates thousands of heterogeneous clinical trial data files in real time and applies trial-specific scientific logic via a proprietary library of reusable configurations. Its platform harmonizes data into operational review workflows and is launching embedded AI agents—starting with Spark, which converts natural language into publication-grade clinical visualizations—with additional agents for proactive data quality monitoring and oversight. The company says its ontology library compounds with each trial, improving performance over time, and that customers have run global trials on the platform producing measurable operational benefits. Rivia positions its stack as an interoperability layer above incumbent systems like Veeva and Medidata, aimed at reducing manual stitching of sources and accelerating decision-making. Near-term plans include scaling the team across Zurich and Boston and deploying next-generation agents to support adaptive and decentralized trial workflows, with the stated ambition of substantially lowering trial costs and speeding insights.

Participated · Equity · Dec 2025

Empathy Health Technologies is the company behind Sober Sidekick, a free mobile application that connects individuals battling substance-use disorders with a 24/7 peer community, daily motivation, professional help and on-demand AA meetings. The app encourages users to both give and receive supportive messages and leverages an “empathy algorithm” that analyzes behavioral and language patterns to predict relapse risk, automatically triggering outreach when danger signs surface. Sober Sidekick has been downloaded nearly 1.1 million times, serves more than 145,000 monthly active users and has facilitated over 2 million peer interactions; an independent analysis found that five interactions on the platform correlate with a 68 % lower likelihood of relapse. While anyone can download the app for free, the company also signs value-based contracts with commercial and public payers. Revenue details were not disclosed, but Empathy Health intends to build a continuous-care infrastructure that shifts reimbursement from crisis response to relapse prevention. With its newest capital, the firm plans to deepen payer partnerships, enhance its predictive technology, and expand member-support operations, including data-science capacity and care-navigation infrastructure. Founded by CEO Chris Thompson, who drew on his own recovery experience, the company ultimately aims to redefine success in substance-use care by measuring sustained relapse prevention rather than episodic treatment.

Led · Seed · Oct 2025

Founded in 2023 by home-health veterans in Pasadena, California, IO Health provides a Care Optimized™ suite—ioAssist™, ioIQ™, and ioDoc™—that delivers real-time validation, education, and best-practice guidance at the point of care without forcing workflow changes or EMR replacement. The patent-pending platform targets the industry’s biggest pain point: accurate documentation that drives faster billing, reduced back-office workload, and better clinical outcomes. Early customer deployments have produced a 25 % reduction in QA rework loops and a 36 % decrease in clinician turnover, underscoring tangible ROI for agencies. Users such as Elevate Home Health report improved functional score accuracy and QA efficiency. The company positions itself as an “intelligent overlay” differentiating through compliance and education capabilities tied directly to financial results. Proceeds from its recent seed financing will be used to expand the Care Optimized suite, including upcoming HOPE functionality for hospice. Prior to this round IO Health had not disclosed any outside capital, leaving the $2 million seed as its primary funding to date.

Led · Seed · Oct 2025

Founded in 2024 in the Netherlands, Datamonk is building the data layer for modern healthcare by automating Picture Archiving and Communication System (PACS) and Vendor Neutral Archive (VNA) migrations. Its agent-based software detects and repairs metadata issues, standardizes study naming, and validates data integrity, enabling hospitals to migrate decades of X-rays, CT scans, and MRIs five to ten times faster than consultant-led projects. By delivering cleaner, interoperable imaging data, the platform supports clinical workflows, research, and the deployment of AI applications. The company was established by Jaap Gielink, Jai Bhatia, and Matthew Condron, who collectively bring deep healthcare, data, and cloud expertise. Datamonk plans to use newly raised capital to advance its AI capabilities, expand its product features, and grow the team. Although revenue and user figures were not disclosed, the recent funding underscores investor confidence in the company’s potential to streamline costly data migration processes across healthcare systems.